Lee Y, Kim HR, Hong MH, Lee KH, et al. A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation. Cancer 2022 Nov 30. doi: 10.1002/cncr.34553.
PMID: 36451343